Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Citi
Farmers Insurance
Argus Health
Cantor Fitzgerald
Queensland Health
Fish and Richardson
Colorcon
Medtronic

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086024

« Back to Dashboard

NDA 086024 describes CAPITAL AND CODEINE, which is a drug marketed by Actavis Mid Atlantic, Valeant Pharms Llc, and Carnrick, and is included in three NDAs. Additional details are available on the CAPITAL AND CODEINE profile page.

The generic ingredient in CAPITAL AND CODEINE is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
Summary for 086024
Tradename:CAPITAL AND CODEINE
Applicant:Valeant Pharms Llc
Ingredient:acetaminophen; codeine phosphate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrength120MG/5ML;12MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Fuji
US Army
Cerilliant
Dow
AstraZeneca
Julphar
US Department of Justice
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.